Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
1.16
Jul. 18, 2025 16:00:00- Change -0.04 (-3.33333%)
- Volume 754,898
- Today's Open 1.21
- Previous Close 1.2
- Today's High 1.235
- Today's Low 1.13
- 52 Week High 4.3
- 52 Week Low 0.85